Table 1.
tOPV | bOPV and IPV (one dose) | bOPV and IPV (two doses) | |
---|---|---|---|
Vaccine regimen | |||
tOPV | 6, 10, and 14 weeks | .. | .. |
bOPV | .. | 6, 10, and 14 weeks | 6, 10, and 14 weeks |
IPV | .. | 14 weeks | 14 and 18 weeks |
BCG | 6 weeks | 6 weeks | 6 weeks |
Measles | 9 and 15 months | 9 and 15 months | 9 and 15 months |
Penta | 6, 10, and 14 weeks | 6, 10, and 14 weeks | 6, 10, and 14 weeks |
PCV | 6, 10, and 18 weeks | 6, 10, and 18 weeks | 6, 10, and 18 weeks |
RotaTeq* | 6, 10, and 14 weeks | 6, 10, and 14 weeks | 6, 10, and 14 weeks |
Rubella | 9 months | 9 months | 9 months |
Stool collection schedule | |||
Enrolment in study | Age 6 weeks | Age 6 weeks | Age 6 weeks |
Day after first oral polio vaccine† | Age 6 weeks + 1 day | Age 6 weeks + 1 day | Age 6 weeks + 1 day |
After completion of polio vaccine regimen | Age 18 weeks | Age 18 weeks | Age 18 weeks |
Day before mOPV2 campaign | Week 0 of mOPV2 campaign | Week 0 of mOPV2 campaign | Week 0 of mOPV2 campaign |
Weekly after mOPV2 campaign (every 7 days) | Weeks 1–10 of mOPV2 campaign | Weeks 1–10 of mOPV2 campaign | Weeks 1–10 of mOPV2 campaign |
Monthly, 10 weeks after mOPV2 campaign (every 28 days) | Weeks 14, 18, and 22 of mOPV2 campaign | Weeks 14, 18, and 22 of mOPV2 campaign | Weeks 14, 18, and 22 of mOPV2 campaign |
Data are age of vaccinated infant for vaccine regimen; and age of infant or time in mOPV2 campaign for stool collection schedule. BCG=bacillus Calmette-Guérin vaccine against tuberculosis. bOPV=bivalent types 1 and 3 oral polio vaccine. IPV=inactivated polio vaccine. mOPV2=monovalent type 2 oral polio vaccine. PCV=pneumococcal conjugate vaccine. Penta=pentavalent vaccine for diphtheria, tetanus, whooping cough, hepatitis B, and Haemophilus influenzae type B. RotaTeq=pentavalent oral vaccine against rotavirus. tOPV=trivalent oral polio vaccine.
Roughly 100 enrolled infants did not receive all or part of the RotaTeq series because of supply issues.
Stool specimens gathered only from enrolled infants.